Biotech's movers for the week of June 8th and a preview of the week ahead
- 4 hours ago
- 1 min read
With M&A news like GSK's $10.6B acquisition of Nuvalent and more positive clinical trial data in the pancreatic cancer space, biotech mostly outperformed the broader market this week.






.png)
